Faeth Therapeutics, Inc. (FTH) vs MiMedx Group, Inc. (MDXG)
A side-by-side comparison of Faeth Therapeutics, Inc. and MiMedx Group, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
FTH
Faeth Therapeutics, Inc.
$27.67HealthcareDelayed quote: Oct 6, 2026, 1:50 PM EDT
MDXG
MiMedx Group, Inc.
$4.60HealthcareDelayed quote: Oct 6, 2026, 1:50 PM EDT
Total return — FTH vs MDXG
growth of $100 · dividends reinvested · last 6yFTH -92.8% (-35.5%/yr)MDXG -53.4% (-12.0%/yr)MDXG compounded faster over this window
Log scale — wide-divergence pair
FTH MDXG
FTH vs MDXG: by the numbers
- •FTH is the larger company ($713M vs $670M market cap).
- •MDXG is profitable (1.76% net margin) while FTH runs a net loss (0.00%).
Metrics side by side
Valuation
| Metric | FTH | MDXG |
|---|---|---|
| P/E ratio | N/A | 114.88 |
| P/S ratio | N/A | 1.89 |
| P/B ratio | 4.12 | 3.10 |
| EV / EBITDA | N/A | 26.24 |
| FCF yield | N/A | 6.06% |
Profitability
| Metric | FTH | MDXG |
|---|---|---|
| Gross margin | 0.00% | 78.85% |
| Operating margin | 0.00% | 15.26% |
| Net margin | 0.00% | 1.76% |
| ROE | -113.05% | 2.89% |
| ROIC | -110.62% | 1.97% |
Growth (annualized)
| Metric | FTH | MDXG |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 6.36% |
| Total return CAGR (5Y) | -31.75% | -4.94% |
Frequently asked
- Is FTH or MDXG more profitable?
- MDXG runs the higher net margin — FTH at 0.00% versus MDXG at 1.76%.
- How have FTH and MDXG total returns compared?
- Over the past 5 years, FTH delivered -31.75% and MDXG delivered -4.94% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
MiMedx P/E ratioFaeth Therapeutics ROEMiMedx ROEFaeth Therapeutics operating marginMiMedx operating marginFaeth Therapeutics revenue growthMiMedx revenue growthFaeth Therapeutics free cash flowMiMedx free cash flow
Faeth Therapeutics & MiMedx appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.